Lung Cancer in Non-Smokers. Prospective descriptive study of a cohort of 68 patients
Abstract
Introduction: Lung cancer in never smokers (LCINS) is considered as a
separate entity given its epidemiological specificities. Materials and methods:
This is a prospective multi-centric epidemiological study of 68 patients treated
and followed for LCINS (less than 100 cigarettes during all lifetime).
Its main objective was to describe clinical features, molecular somatic profile,
the risk-factors exposure, and survey in never smokers. Results: Between
juin2017 and februry2019 a cohort of 60 (88%) women and 08 (12%) men was
collected, with a median age of 59 years.Two-third were exposed to passive
smoking (mainly women and in domestic setting). Domestic use of biofuels is
present in 43% of cases and the exposure to cooking oil is almost present in
women, with median duration of 10 years. The frequent common symptom is
cough in 43% of cases. Thoracic CT found opacity in 94% cases ; peripheral
topography is present in 63% of cases. Adenocarcinoma is found in 75% of
cases, and the EGFR mutation is present in 34% of cases. The majority of
patients are classified as stage IV (74%), systemic treatment is used in 98% of
cases. After follow-up time of 10 months, the therapeutic results are marked
by objective response in 44% of cases; radiological stability is maintained in
41% of cases. Overall survival is 15,4 months with extremes of 03 and 24
months. Conclusion: LCINS is an interesting entity for the study of nontobacco-related cancer risk factors.
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.